Valar Labs uses AI to read tumor slides and predict treatment response, beginning with a bladder-cancer test for BCG therapy.

Cosigns

Team

Jobs

Funding

Total raised
Undisclosed
Last valuation
Undisclosed
Series
Series A

Data current as of May 30, 2024